Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
HCM
#1782
HUTCHMED (China) Limited American Depositary Shares
15.2
1
USD
-0.46%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-0.46%
Changement Mensuel
+8.64%
Evolution sur 6 mois
-0.65%
Changement Annuel
+5.41%
Clôture Précédente
15.2
8
Open
15.2
1
Bid
Ask
Low
15.2
1
High
15.2
1
Volume
1
Marchés
Actions des Marchés US
Soins de Santé
HCM
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
145.54 M
172.91 M
172.96 M
174.25 M
174.32 M
174.47 M
695.99 M
Valuation ratios
Enterprise value
4.5 B
5.78 B
2.57 B
2.84 B
2.44 B
2.34 B
10.19 B
Price to earnings ratio
-177.74
-140.32
-38.09
145.92
360.25
25.63
493.71
Price to sales ratio
98.03
78.08
32.54
18.16
19.96
21.21
—
Price to cash flow ratio
-360.06
-136.16
-51.66
69.41
25.31 K
-179.96
25.14 K
Price to book ratio
46.16
28.18
22.73
20.83
16.55
9.4
69.52
Enterprise value to EBITDA ratio
-121.2
-93.43
-34.78
566.71
-345.05
-449.92
—
Profitability ratios
Return on assets %
-0.17
-0.14
-0.35
0.08
0.03
0.26
-0.04
Return on equity %
-0.24
-0.19
-0.57
0.14
0.05
0.37
-0.06
Return on invested capital %
-330.91
-445.2
-430.31
16.02
-30.76
-31.12
—
Gross margin %
100
100
100
100
44.64
38.68
—
Operating margin %
-86.27
-92.19
-95.61
2.19
-6.94
-7.14
—
EBITDA margin %
-83.61
-90.17
-93.58
3.17
-5.75
-4.73
—
Net margin %
-55.15
-54.66
-84.62
12.03
5.99
83.3
—
Liquidity ratios
Quick ratio
3.23
3.77
2.21
2.6
2.7
4.83
12.34
Current ratio
3.35
3.89
2.37
2.72
2.83
4.96
12.89
Inventory turnover
—
—
—
—
6.93
7.35
—
Asset turnover
0.38
0.34
0.36
0.73
0.49
0.36
—
Solvency ratios
Debt to assets ratio
0.05
0.03
0.03
0.04
0.05
0.04
0.16
Debt to equity ratio
0.07
0.04
0.04
0.08
0.09
0.06
0.27
Long term debt to total assets ratio
0.04
0.02
0.02
0.04
0.05
0.04
0.14
Long term debt to total equity ratio
0.06
0.03
0.03
0.07
0.08
0.06
0.23
Per share metrics
Operating cash flow per share
-0.09
-0.26
-0.32
0.25
0
-0.07
-0.09
EBIT per share
-0.28
-0.41
-0.48
0.02
-0.05
-0.04
—
EBITDA per share
-0.27
-0.41
-0.47
0.03
-0.04
-0.03
—
Total debt per share
0.05
0.05
0.03
0.06
0.08
0.08
0.25
Cash per share
0.62
1.28
0.74
1.02
0.96
1.57
4.29
Net current asset value per share
0.76
1.53
0.99
1.26
1.22
1.8
5.27
Tangible book value per share
0.69
1.24
0.72
0.84
0.87
1.4
3.83
Working capital per share
0.53
1.14
0.57
0.8
0.79
1.43
3.6
Book value per share
0.69
1.25
0.72
0.84
0.87
1.42
3.85
Nouvelles
HUTCHMED tiendra son assemblée annuelle 2026 le 12 mai à Hong-Kong
HUTCHMED lance un essai de phase III du HMPL-760 pour le lymphome en Chine
Les dirigeants de Hutchmed reçoivent des actions acquises
Hutchmed executives receive vested share awards
Hutchmed retire son médicament anticancéreux Tazverik en Chine
Hutchmed withdraws cancer drug Tazverik in China
Un administrateur indépendant de HUTCHMED prendra sa retraite après huit ans
HUTCHMED independent director to retire after eight years
HUTCHMED mars 2026 : 1,4 milliard$ de trésorerie alimente la plateforme ATTC
HUTCHMED March 2026 slides: $1.4B cash fuels ATTC platform push
HUTCHMED affiche une forte croissance en 2025, l’action recule
HUTCHMED lance un essai d’un médicament PI3K/PIKK-EGFR dans les tumeurs solides